Display Settings:

Format

Send to:

Choose Destination
    Pharmacopsychiatry. 2000 Mar;33(2):78-80.

    Healthy outcome under olanzapine treatment in a pregnant woman.

    Source

    Institute for Clinical Pharmacology, Charité, Humboldt University Berlin, Germany.

    Abstract

    Our report focuses on the case of a pregnant women with recurrent, paranoid schizophrenia. The patient was treated with Olanzapine from the 18th gestational week until delivery and during breast-feeding. No adverse events occurred during pregnancy, and the outcome was healthy. After delivery, the plasma level of olanzapine in the infant was one-third of the maternal plasma level, and during breast-feeding, it decreased to an undetectable limit.

    PMID:
    10761825
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk